Posted on 8 月 24, 20218/24/21
CHALLENGING TRADITION: The argument for integrated commercialization to improve operational agility
Posted on 7 月 26, 20217/26/21
Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation
Posted on 7 月 13, 20217/13/21
The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making
Posted on 6 月 29, 20216/29/21
Next Gen Commercialization: Accelerating Patient Access to Life-Changing Therapies
Posted on 6 月 29, 20216/29/21
A SpaceX Philosophy to Launching in Pharma
Posted on 6 月 4, 20216/4/21
Engaging Oncology Patients and Providers in The Age of COVID And Beyond
Posted on 5 月 17, 20215/17/21
Gross-To-Net: Challenges and Best Practices
Posted on 2 月 17, 20212/17/21
The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value
Posted on 2 月 5, 20212/5/21
Drug Pricing And Drug Price Reporting Regulatory Update
Posted on 11 月 18, 202011/18/20